AnaptysBio Inc.

NASDAQ: ANAB · Real-Time Price · USD
20.15
0.36 (1.82%)
At close: Aug 20, 2025, 3:59 PM
20.15
0.00%
After-hours: Aug 20, 2025, 04:26 PM EDT

AnaptysBio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-38.63M -39.33M -21.78M -32.85M -46.66M -43.94M -42.21M -37.31M -39.84M -44.26M -26.41M -33.5M -32.55M -36.26M -32.54M -6.67M -429K -18.16M
Depreciation & Amortization
601K 606K 601K 596K 595K 605K 604K 592K 587K 593K 606K 585K 571K 573K 385K 669K 911K 125K
Stock-Based Compensation
9.24M 9.17M 8.18M 8.19M 7.54M 10.13M 8.11M 7.81M 8.43M 8.86M 6.68M 6.27M 6.66M 7.74M 3.98M 4.36M 3.69M 3.31M
Other Working Capital
-3.61M 3.61M -158K -6.84M 2.62M -1.99M 2.42M -6.21M -1.7M -340K 1.32M 2.44M -4.49M -1.58M 6.64M -5.15M -1.21M 372.66M
Other Non-Cash Items
27.25M 16.39M 15.1M 15.3M 18.05M 13.16M 4.96M 4.43M 4.36M 2.15M 2.53M 5.35M 5.71M 5.01M 1.55M 85K 126K 167K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -3.15M -2.99M -2.18M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-29.46M 2.46M -68.78M -1.32M 8.72M -7.4M -2.66M -9M 3.25M 8.09M 5.91M 3.55M -4.53M 1.91M 1.32M -5.46M 5.29M -8.65M
Operating Cash Flow
-40.24M -10.7M -66.67M -10.09M -14.38M -44.19M -34.35M -36.47M -25.41M -24.57M -10.69M -17.75M -24.15M -21.01M -25.3M -7.01M 9.59M -23.2M
Capital Expenditures
-39K -35K -263K -35K -33K -27K -280K -162K -190K -175K -175K -50K -78K -55K -14K -172K -863K -317K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -49.46M -30.8M 20.27M -85.57M -21.67M 32.38M 70.92M n/a 1.38M 15K n/a 6.24M
Purchase of Investments
-54.21M -122.55M -120.88M -51.34M -149.15M -59M -66.31M -70.05M -119.01M -48.55M -127.58M -180.13M -172.32M -322.48M -92.18M -16.75M -3.5M -6.24M
Sales Maturities Of Investments
90.65M 137.43M 91.75M 110M 146.74M 127.64M 115.77M 100.84M 98.74M 134.13M 149.25M 147.75M 101.4M 9.62M 25.5M 27.74M 42.32M 63.28M
Other Investing Acitivies
n/a n/a n/a n/a -2.41M 68.64M 49.46M 30.8M -20.27M 85.57M 21.67M -32.38M -70.92M -312.86M -1.38M 15K 38.82M -6.24M
Investing Cash Flow
36.4M 14.85M -29.4M 58.62M -2.44M 68.62M 49.18M 30.64M -20.45M 85.4M 21.5M -32.43M -71M -312.91M -66.69M 10.84M 37.96M 56.73M
Debt Repayment
-823K n/a n/a -26.9M 33.97M n/a n/a n/a -1.8M -1.27M n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-51.1M -4.42M -456K n/a n/a n/a n/a n/a -12.47M -37.53M n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -24.46M 27.47M -370K n/a -14.44M -5.42M -3.23M n/a -43K -1.47M 34.33M -433K -235K 251.34M n/a n/a n/a
Financial Cash Flow
-50.5M -28.59M 27.57M 71.23M 34.95M -6.69M -5.16M -3.07M -13.49M -37.57M 1.95M 37.03M 432K 4.61M 251.34M 241K 554K 167K
Net Cash Flow
-54.34M -24.44M -68.5M 119.76M 18.13M 17.73M 9.67M -8.91M -59.36M 23.25M 12.76M -13.15M -94.71M -329.32M 159.34M 4.07M 48.11M 33.69M
Free Cash Flow
-40.28M -10.73M -66.94M -10.13M -14.41M -44.22M -34.63M -36.64M -25.6M -24.74M -10.86M -17.8M -24.23M -21.07M -25.32M -7.18M 8.73M -23.52M